Vectura Group Share Price (VEC)

142.25 -0.50 (-0.35%) delayed: 1:04PM BST
Bid price 142.00 Open price 143.50
Ask price 142.50 Prev close 142.75
High price 143.75 Spread 0.35%
Low price 141.25 Volume 1,730,421

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index n/a

Vectura Group Key Numbers

Latest Share Price (p) 142.25 Net Gearing (%) -0.13
Market Capitalisation (£m) 578.87 Gross Gearing (%) 26.40
Shares in issue (m) 401.63 Debt Ratio 22.10
P/E Ratio -205.90 Debt-to-Equity Ratio 0.79
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.36
Dividend Yield (%) 0.00 Price to book value 2.55
Dividend cover (x) 0.00 ROCE -0.03
Earning per share (p) -0.70 EPS Growth (%) 61.11
52 week high / low 171.50 / 80.25 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
08/07/2014 BUY Dr Christopher Blackwell CEO 1,212
08/07/2014 BUY Dr Trevor Phillips ED 1,212
08/07/2014 BUY Paul Oliver FD 1,212
02/07/2014 EXR John Brown NED 238,989
02/07/2014 SEXR John Brown NED 159,100

More Vectura Group Director Deals >>

Vectura Group Company News

17:27 17/07/2014

Additional Listing - replacement

/* */ RNS Number : 6683M Vectura Group plc 17 July 2014    Vectura Group plc (the "Company")   ADDITIONAL LISTING - REPLACEMENT   The following amendment has been made to the Additional Listing announcement released on 14 July 2014 at...

11:13 14/07/2014

Additional Listing

/* */ RNS Number : 2155M Vectura Group plc 14 July 2014    Vectura Group plc (the "Company")   ADDITIONAL LISTING     Chippenham, UK, 14 July 2014: Vectura Group plc (LSE: VEC), announces that application has been made to...

16:10 08/07/2014

Director Deals - Vectura Group PLC (VEC)

Paul Oliver, Financial Director, bought 1,212 shares in the company on the 7th July 2014 at a price of 148.50p. The Director now holds 104,515 shares. NOTE: SIP Purchase: Also awarded 1212 matching shares Story provided by Director deals data provided by...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

26 days ago


Powered by IST's

Register now for FREE Vectura Group share price discussions